A 10-year-old boy who falls asleep while laughing

It does not matter at all what century we live in and today is the age of technology or the Middle Ages; The medical world has always created surprises for humans and surprised the world. Josh Hadfield, a 10-year-old boy, is a surprise to the medical world these days because he had a strange complication after receiving the swine flu vaccine; So that after each laugh, he has a seizure and falls asleep. Then join us to tell you the story of this boy and the complication of Pandemrix.

Every time Josh Hadfield laughs while watching a movie on his iPad, he has a seizure and faints. The problem began when Josh received the swine flu vaccine in 2010.
Not only does he faint once every five minutes, but he also suffers from sleep attacks. This condition causes him to lose control of his body due to muscle weakness. His body movements and movements sometimes make it look as if he has a seizure.
A video posted by him on the Internet shows that Josh is facing this situation on a daily basis. In this situation, he can not walk, eat or even simply laugh. “Attacks have become normal for her,” said Joshfield, Josh’s mother, 45. He keeps his emotions to himself and tries not to laugh. “He had two attacks this morning and will probably face four or five more by nightfall.”
“It happens when he laughs, gets excited or somehow expresses his feelings. He is only 10 years old. “So, it is natural for him to want to express his feelings, but in this situation he is trying to suppress them.” Josh contracted the condition three weeks after receiving the swine flu vaccine on January 21, 2010.
This complication is also known as Pandemrix. Ms Hadfield claims that within a few weeks of receiving the vaccine, Josh had undergone significant changes. He is currently suffering from sleep attacks that take control of his body muscles. These symptoms were not seen in him before the vaccine was given. He faints every five minutes, even while walking, eating, or swimming, and has seizures when he laughs.
“We plan to do more research in this area,” said a spokesman for GlaxoSmithKline Pharmaceuticals. “We are also trying to support the research of other individuals and institutions in relation to such cases.” Source: Dr. Aloo

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button